首页 > 最新文献

Biomedical Papers-Olomouc最新文献

英文 中文
Acute kidney injury due to gentamicin nephrotoxicity and specific miRNAs as biomarkers. 庆大霉素肾毒性导致的急性肾损伤和作为生物标志物的特异性 miRNA。
IF 0.7 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-10-11 DOI: 10.5507/bp.2024.031
Viktor Klementa, Nadezda Petejova, Pavel Horak, Ester Kurasova, Josef Zadrazil

Acute kidney injury (AKI) due to gentamicin nephrotoxicity is a significant concern in clinical medicine, particularly in patients receiving prolonged or high-dose gentamicin therapy. Gentamicin is an aminoglycoside antibiotic frequently used in the treatment of a range of bacterial infections. However, its use is associated with nephrotoxicity which can manifest as AKI. Due to this, it is crucial to diagnose promptly and manage treatment effectively. Ongoing studies are therefore focusing on non-protein-coding RNAs as potential biomarkers for AKI. Numerous microRNAs (miRNAs) have been implicated in gentamicin-induced nephrotoxicity and AKI. They participate in pathways associated with inflammation, cell death, and oxidative stress and each of these factors play critical roles in the development of gentamicin-induced kidney injury. Research studies have demonstrated changes in the expression levels of these miRNAs in response to gentamicin exposure both in vitro and in in vivo models, as well as in human clinical trials involving patients receiving gentamicin therapy. The dysregulation of these miRNAs correlates with the severity of kidney injury and may serve as sensitive biomarkers for early detection and monitoring of AKI induced by gentamicin.

庆大霉素肾毒性导致的急性肾损伤(AKI)是临床医学中的一个重要问题,尤其是在接受长期或大剂量庆大霉素治疗的患者中。庆大霉素是一种氨基糖苷类抗生素,常用于治疗各种细菌感染。然而,它的使用与肾毒性有关,肾毒性可表现为 AKI。因此,及时诊断和有效治疗至关重要。因此,正在进行的研究将非蛋白编码 RNA 作为潜在的 AKI 生物标志物。许多微小 RNA(miRNA)都与庆大霉素诱导的肾毒性和 AKI 有关。它们参与了与炎症、细胞死亡和氧化应激相关的通路,而这些因素在庆大霉素诱导的肾损伤的发展过程中都起着至关重要的作用。研究表明,这些 miRNA 在体外和体内模型以及接受庆大霉素治疗的人体临床试验中的表达水平会随着庆大霉素暴露而发生变化。这些 miRNA 的失调与肾损伤的严重程度相关,可作为早期检测和监测庆大霉素诱导的 AKI 的灵敏生物标志物。
{"title":"Acute kidney injury due to gentamicin nephrotoxicity and specific miRNAs as biomarkers.","authors":"Viktor Klementa, Nadezda Petejova, Pavel Horak, Ester Kurasova, Josef Zadrazil","doi":"10.5507/bp.2024.031","DOIUrl":"https://doi.org/10.5507/bp.2024.031","url":null,"abstract":"<p><p>Acute kidney injury (AKI) due to gentamicin nephrotoxicity is a significant concern in clinical medicine, particularly in patients receiving prolonged or high-dose gentamicin therapy. Gentamicin is an aminoglycoside antibiotic frequently used in the treatment of a range of bacterial infections. However, its use is associated with nephrotoxicity which can manifest as AKI. Due to this, it is crucial to diagnose promptly and manage treatment effectively. Ongoing studies are therefore focusing on non-protein-coding RNAs as potential biomarkers for AKI. Numerous microRNAs (miRNAs) have been implicated in gentamicin-induced nephrotoxicity and AKI. They participate in pathways associated with inflammation, cell death, and oxidative stress and each of these factors play critical roles in the development of gentamicin-induced kidney injury. Research studies have demonstrated changes in the expression levels of these miRNAs in response to gentamicin exposure both in vitro and in in vivo models, as well as in human clinical trials involving patients receiving gentamicin therapy. The dysregulation of these miRNAs correlates with the severity of kidney injury and may serve as sensitive biomarkers for early detection and monitoring of AKI induced by gentamicin.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142481499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adrenal insufficiency - causes and laboratory diagnosis. 肾上腺功能不全--病因和实验室诊断。
IF 0.7 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-10-07 DOI: 10.5507/bp.2024.033
Tomas Brutvan, Jana Jezkova, Marcela Kotasova, Michal Krsek

Adrenal insufficiency (AI) manifests as a clinical syndrome arising from either the direct impairment of adrenal glands, leading to primary AI characterized by deficiencies in glucocorticoids and mineralocorticoids, or adrenal cortex atrophy due to diminished adrenocorticotropic hormone (ACTH) stimulation, a consequence of hypothalamic and/or pituitary damage, resulting in secondary AI. The diagnosis of AI is based on clinical assessment and biochemical tests, including basal hormone level measurements and stimulation tests. In evaluating the results of laboratory tests, it is necessary to consider factors that may influence both pre-analytical and analytical phases, as well as the chosen methodology. Correct diagnosis of adrenal insufficiency and timely initiation of suitable replacement therapy are paramount. These steps are crucial not only for managing the condition but also to avert potentially life-threatening adrenal crises.

肾上腺功能不全(AI)表现为一种临床综合征,是由于肾上腺直接受损,导致以糖皮质激素和矿物质皮质激素缺乏为特征的原发性 AI,或由于下丘脑和/或垂体受损导致促肾上腺皮质激素(ACTH)刺激减弱而引起肾上腺皮质萎缩,从而导致继发性 AI。AI 的诊断基于临床评估和生化检验,包括基础激素水平测量和刺激试验。在评估实验室检测结果时,有必要考虑可能影响分析前和分析阶段的因素,以及所选择的方法。正确诊断肾上腺功能不全并及时启动合适的替代疗法至关重要。这些步骤不仅对控制病情至关重要,而且还能避免可能危及生命的肾上腺危象。
{"title":"Adrenal insufficiency - causes and laboratory diagnosis.","authors":"Tomas Brutvan, Jana Jezkova, Marcela Kotasova, Michal Krsek","doi":"10.5507/bp.2024.033","DOIUrl":"https://doi.org/10.5507/bp.2024.033","url":null,"abstract":"<p><p>Adrenal insufficiency (AI) manifests as a clinical syndrome arising from either the direct impairment of adrenal glands, leading to primary AI characterized by deficiencies in glucocorticoids and mineralocorticoids, or adrenal cortex atrophy due to diminished adrenocorticotropic hormone (ACTH) stimulation, a consequence of hypothalamic and/or pituitary damage, resulting in secondary AI. The diagnosis of AI is based on clinical assessment and biochemical tests, including basal hormone level measurements and stimulation tests. In evaluating the results of laboratory tests, it is necessary to consider factors that may influence both pre-analytical and analytical phases, as well as the chosen methodology. Correct diagnosis of adrenal insufficiency and timely initiation of suitable replacement therapy are paramount. These steps are crucial not only for managing the condition but also to avert potentially life-threatening adrenal crises.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of Fetuin-A and Leucine-rich α-2-glycoprotein in the diagnosis of prostate cancer - a pilot study. Fetuin-A和富亮氨酸α-2-糖蛋白在前列腺癌诊断中的作用--一项试点研究。
IF 0.7 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-27 DOI: 10.5507/bp.2024.028
Alena Sorokac Kubolkova, Gabriel Varga, Miroslava Benovska, Lenka Kovacova, Michal Fedorko

Background: Prostate cancer (PC) is one of the most frequently diagnosed non-skin solid cancers and is a leading cause of cancer-related death and the incidence increasing. Early diagnosis of the disease improves the outcomes. There is an urgent need for new biomarkers with greater discriminative precision for diagnosis, risk-stratification and treatment. The aim of our study was to evaluate the diagnostic and prognostic potential of Fetuin-A and LRG1 in patients with PC.

Methods: Serum levels of Fetuin-A and LRG1 were compared in patients with PC (n=46), a control group 1 including young, healthy subjects (n=26) and control group 2 including patients with negative prostate biopsy (n=46). In PC patients, the levels of both biomarkers were compared in subgroups with different tumour characteristics.

Results: We demonstrated a statistically significant higher concentrations of Fetuin-A in PC patients compared to control group 2 (439 mg/L vs. 372 mg/L), P<0.001. No statistically significant difference was found between PC patients and control group 1, nor for LRG1 levels between the three groups. In PC patients, higher serum levels of LRG1 were found in M1 patients compared to M0 (98 mg/L vs. 42 mg/L), P=0.059.

Conclusion: Fetuin-A levels are significantly higher in patients with prostate cancer than in patients without malignancy but LRG1 levels do not differ between patients with PC and controls.

背景:前列腺癌(PC)是最常见的非皮肤实体癌之一,也是癌症相关死亡的主要原因之一,而且发病率还在不断上升。疾病的早期诊断可改善预后。目前急需新的生物标志物来提高诊断、风险分级和治疗的精确度。我们的研究旨在评估 Fetuin-A 和 LRG1 在 PC 患者中的诊断和预后潜力:方法:比较了PC患者(46人)、对照组1(包括年轻健康人)(26人)和对照组2(包括前列腺活检阴性患者)(46人)血清中Fetuin-A和LRG1的水平。在 PC 患者中,这两种生物标志物的水平在具有不同肿瘤特征的亚组中进行了比较:结果:与对照组 2 相比,我们发现 PC 患者的 Fetuin-A 浓度明显更高(439 mg/L vs. 372 mg/L):前列腺癌患者的Fetuin-A水平明显高于非恶性肿瘤患者,但PC患者和对照组的LRG1水平没有差异。
{"title":"The role of Fetuin-A and Leucine-rich α-2-glycoprotein in the diagnosis of prostate cancer - a pilot study.","authors":"Alena Sorokac Kubolkova, Gabriel Varga, Miroslava Benovska, Lenka Kovacova, Michal Fedorko","doi":"10.5507/bp.2024.028","DOIUrl":"https://doi.org/10.5507/bp.2024.028","url":null,"abstract":"<p><strong>Background: </strong>Prostate cancer (PC) is one of the most frequently diagnosed non-skin solid cancers and is a leading cause of cancer-related death and the incidence increasing. Early diagnosis of the disease improves the outcomes. There is an urgent need for new biomarkers with greater discriminative precision for diagnosis, risk-stratification and treatment. The aim of our study was to evaluate the diagnostic and prognostic potential of Fetuin-A and LRG1 in patients with PC.</p><p><strong>Methods: </strong>Serum levels of Fetuin-A and LRG1 were compared in patients with PC (n=46), a control group 1 including young, healthy subjects (n=26) and control group 2 including patients with negative prostate biopsy (n=46). In PC patients, the levels of both biomarkers were compared in subgroups with different tumour characteristics.</p><p><strong>Results: </strong>We demonstrated a statistically significant higher concentrations of Fetuin-A in PC patients compared to control group 2 (439 mg/L vs. 372 mg/L), P<0.001. No statistically significant difference was found between PC patients and control group 1, nor for LRG1 levels between the three groups. In PC patients, higher serum levels of LRG1 were found in M1 patients compared to M0 (98 mg/L vs. 42 mg/L), P=0.059.</p><p><strong>Conclusion: </strong>Fetuin-A levels are significantly higher in patients with prostate cancer than in patients without malignancy but LRG1 levels do not differ between patients with PC and controls.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous transthoracic needle biopsy of lung lesions is a safe method associated with a very low risk of pleural recurrence. 经皮经胸针活检肺部病变是一种安全的方法,胸膜复发的风险非常低。
IF 0.7 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-27 DOI: 10.5507/bp.2024.030
Martin Svaton, David Havel, Marcela Buresova, Jan Baxa, Petr Hosek

Aim: Percutaneous transthoracic needle biopsy (PTNB), an alternative to bronchoscopic confirmation of lung lesions, is today being associated with a risk of pneumothorax and hemorrhage. Further, there are no data on the possible risk of malignant disease spreading to the pleura at the site of the PTNB. Previous studies have dealt with this risk in stage I non-small cell lung cancer only. The aim of this study was thus to assess the risk of pleural recurrence for all types of lung lesions. Secondary objectives included assessment of diagnostic yield and safety with respect to the incidence of pneumothorax and hemorrhage.

Methods: Clinical data of all patients from the University Hospital in Pilsen who had undergone PTNB of lung lesions between 1.1.2018 and 31.12.2022 were included in this retrospective study.

Results: Following PTNB, ipsilateral pleural effusion occurred in 4.8% of patients without prior pleural infiltration. The effusion was confirmed as malignant in one patient (0.7%). Diagnostic yield of the method was 86.6%. We recorded pneumothorax or hemorrhage in the lung parenchyma or pleural space requiring medical intervention in 3.4% and 1.1% of patients, respectively.

Conclusion: In our study, percutaneous transthoracic needle biopsy of lung lesions showed high sensitivity and low degree of acute complications requiring an invasive solution. The risk of pleural recurrence after a biopsy was very low. Consequently, we continue to consider this method to be an alternative to bronchoscopy biopsies.

目的:经皮经胸穿刺活检术(PTNB)是支气管镜确认肺部病变的一种替代方法,但目前存在气胸和出血的风险。此外,目前还没有数据显示恶性疾病在PTNB部位扩散到胸膜的可能风险。以往的研究只涉及 I 期非小细胞肺癌的这种风险。因此,本研究旨在评估所有类型肺部病变的胸膜复发风险。次要目标包括评估诊断率以及气胸和出血发生率方面的安全性:这项回顾性研究纳入了比尔森大学医院在2018年1月1日至2022年12月31日期间接受肺部病变PTNB治疗的所有患者的临床数据:4.8%的患者在PTNB术后出现同侧胸腔积液,且之前未出现胸膜浸润。一名患者(0.7%)的积液被确诊为恶性。该方法的诊断率为 86.6%。我们分别记录了3.4%和1.1%的患者出现气胸或肺实质或胸膜腔出血,需要进行医疗干预:在我们的研究中,经皮经胸针活检肺部病变显示出较高的灵敏度和较低的急性并发症发生率。活检后胸膜复发的风险非常低。因此,我们仍然认为这种方法可以替代支气管镜活检。
{"title":"Percutaneous transthoracic needle biopsy of lung lesions is a safe method associated with a very low risk of pleural recurrence.","authors":"Martin Svaton, David Havel, Marcela Buresova, Jan Baxa, Petr Hosek","doi":"10.5507/bp.2024.030","DOIUrl":"https://doi.org/10.5507/bp.2024.030","url":null,"abstract":"<p><strong>Aim: </strong>Percutaneous transthoracic needle biopsy (PTNB), an alternative to bronchoscopic confirmation of lung lesions, is today being associated with a risk of pneumothorax and hemorrhage. Further, there are no data on the possible risk of malignant disease spreading to the pleura at the site of the PTNB. Previous studies have dealt with this risk in stage I non-small cell lung cancer only. The aim of this study was thus to assess the risk of pleural recurrence for all types of lung lesions. Secondary objectives included assessment of diagnostic yield and safety with respect to the incidence of pneumothorax and hemorrhage.</p><p><strong>Methods: </strong>Clinical data of all patients from the University Hospital in Pilsen who had undergone PTNB of lung lesions between 1.1.2018 and 31.12.2022 were included in this retrospective study.</p><p><strong>Results: </strong>Following PTNB, ipsilateral pleural effusion occurred in 4.8% of patients without prior pleural infiltration. The effusion was confirmed as malignant in one patient (0.7%). Diagnostic yield of the method was 86.6%. We recorded pneumothorax or hemorrhage in the lung parenchyma or pleural space requiring medical intervention in 3.4% and 1.1% of patients, respectively.</p><p><strong>Conclusion: </strong>In our study, percutaneous transthoracic needle biopsy of lung lesions showed high sensitivity and low degree of acute complications requiring an invasive solution. The risk of pleural recurrence after a biopsy was very low. Consequently, we continue to consider this method to be an alternative to bronchoscopy biopsies.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary ventriculitis caused by Streptococcus intermedius - a rare case and challenge with uncertain clinical outcome. Case report. 中间链球菌引起的原发性脑室炎--一个罕见病例和临床结果不确定的挑战。病例报告。
IF 0.7 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-27 DOI: 10.5507/bp.2024.029
Stefan Trnka, Premysl Stejskal, Jakub Jablonsky, David Krahulik, Eva Cechakova, Lumir Hrabalek

Aims: To present a case of primary ventriculitis in a 53-year-old patient caused by Streptococcus intermedius, emphasizing the rarity of the condition and the challenges in achieving clinical improvement despite targeted therapy.

Methods: The patient underwent clinical evaluation, including CT and MRI imaging, as well as CSF analysis. Empirical antibiotic therapy was initiated with cefotaxime and metronidazole, followed by targeted therapy based on CSF culture results. External ventricular drainage was performed surgically.

Results: No predisposing factors were identified in the patient. Initial imaging showed no acute changes, but follow-up imaging revealed significant ventricular inflammation. CSF analysis confirmed the presence of Streptococcus intermedius. Despite early and targeted antibiotic therapy, and surgical intervention, the patient's clinical condition did not improve.

Conclusion: This case highlights the rarity of primary ventriculitis caused by Streptococcus intermedius and the challenges in managing it. The lack of clinical improvement despite prompt and targeted treatment underscores the need for further research to develop more effective therapeutic strategies for such infections.

目的:介绍一例由中间链球菌引起的原发性脑室炎(53 岁)患者的病例,强调该病症的罕见性以及靶向治疗在改善临床症状方面所面临的挑战:患者接受了临床评估,包括 CT 和核磁共振成像以及脑脊液分析。开始使用头孢他啶和甲硝唑进行经验性抗生素治疗,随后根据脑脊液培养结果进行针对性治疗。手术进行了脑室外引流:结果:未发现患者有诱发因素。初步影像学检查未发现急性病变,但随访影像学检查发现心室有明显炎症。脑脊液分析证实存在中间链球菌。尽管早期进行了有针对性的抗生素治疗和手术干预,但患者的临床状况并未改善:本病例凸显了中间链球菌引起的原发性脑室炎的罕见性和治疗的挑战性。尽管进行了及时和有针对性的治疗,但临床症状仍未得到改善,这凸显了进一步研究的必要性,以便针对此类感染制定更有效的治疗策略。
{"title":"Primary ventriculitis caused by Streptococcus intermedius - a rare case and challenge with uncertain clinical outcome. Case report.","authors":"Stefan Trnka, Premysl Stejskal, Jakub Jablonsky, David Krahulik, Eva Cechakova, Lumir Hrabalek","doi":"10.5507/bp.2024.029","DOIUrl":"https://doi.org/10.5507/bp.2024.029","url":null,"abstract":"<p><strong>Aims: </strong>To present a case of primary ventriculitis in a 53-year-old patient caused by Streptococcus intermedius, emphasizing the rarity of the condition and the challenges in achieving clinical improvement despite targeted therapy.</p><p><strong>Methods: </strong>The patient underwent clinical evaluation, including CT and MRI imaging, as well as CSF analysis. Empirical antibiotic therapy was initiated with cefotaxime and metronidazole, followed by targeted therapy based on CSF culture results. External ventricular drainage was performed surgically.</p><p><strong>Results: </strong>No predisposing factors were identified in the patient. Initial imaging showed no acute changes, but follow-up imaging revealed significant ventricular inflammation. CSF analysis confirmed the presence of Streptococcus intermedius. Despite early and targeted antibiotic therapy, and surgical intervention, the patient's clinical condition did not improve.</p><p><strong>Conclusion: </strong>This case highlights the rarity of primary ventriculitis caused by Streptococcus intermedius and the challenges in managing it. The lack of clinical improvement despite prompt and targeted treatment underscores the need for further research to develop more effective therapeutic strategies for such infections.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasonographic signs as predictors of metastatic involvement in the axillary lymph nodes in breast cancer patients: from minimal changes to the appearance of the pathological lymph node. A retrospective analysis. 预测乳腺癌患者腋窝淋巴结转移的超声波征象:从最小变化到病理淋巴结的出现。回顾性分析。
IF 0.7 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 Epub Date: 2023-03-10 DOI: 10.5507/bp.2023.009
Lucia Veverkova, Marketa Koleckova, Katherine Vomackova, Nora Zlamalova, Lubica Lowova

Introduction: The aim of this study was to retrospectively analyse the ultrasound findings in the axillary lymph nodes in breast cancer patients with morphological changes that required biopsy. In most cases the morphological changes were minimal.

Materials and methods: Between January 2014 and September 2019 examination of axillary lymph nodes with subsequent core-biopsy was performed in 185 breast cancer patients at the Department of Radiology. Lymph node metastases were detected in 145 cases, while in the remaining 40 cases benign changes or normal lymph node (LN) histology was observed. Ultrasound morphological characteristics and the sensitivity and specificity were evaluated retrospectively. Seven ultrasound characteristics were evaluated - diffuse cortical thickening, focal cortical thickening, absence of the hilum, cortical non-homogeneities, L/T ratio (longitudinal to transverse axis), type of vascularization and perinodal oedema.

Results and conclusion: It is a diagnostic challenge to recognize metastases in the lymph nodes with minimal morphological changes. The most specific signs are non-homogeneities in the cortex of the lymph node as well as the absence of fat hilum and perinodal oedema. Metastases are significantly more frequent in LNs with a lower L/T ratio, in LNs with perinodal oedema and with a peripheral type of vascularization. Biopsy of these lymph nodes is necessary to confirm or exclude metastases, especially if it affects the type of treatment.

导言本研究旨在回顾性分析乳腺癌患者腋窝淋巴结的超声检查结果,这些患者的腋窝淋巴结形态发生变化,需要进行活检。大多数病例的形态学变化很小:2014年1月至2019年9月期间,放射科对185名乳腺癌患者进行了腋窝淋巴结检查和随后的核心活检。其中 145 例发现淋巴结转移,其余 40 例为良性变化或淋巴结组织学正常。对超声形态特征、敏感性和特异性进行了回顾性评估。评估了七个超声特征--弥漫性皮质增厚、局灶性皮质增厚、无蒂、皮质不均质、L/T 比值(纵轴与横轴)、血管类型和结节周围水肿:在形态学变化极小的情况下识别淋巴结转移是一项诊断挑战。最特异的征象是淋巴结皮质不均质、无脂肪帽和结节周围水肿。L/T比值较低的淋巴结、结周水肿的淋巴结和周围血管类型的淋巴结发生转移的频率明显较高。有必要对这些淋巴结进行活检,以确认或排除转移灶,尤其是在影响治疗类型的情况下。
{"title":"Ultrasonographic signs as predictors of metastatic involvement in the axillary lymph nodes in breast cancer patients: from minimal changes to the appearance of the pathological lymph node. A retrospective analysis.","authors":"Lucia Veverkova, Marketa Koleckova, Katherine Vomackova, Nora Zlamalova, Lubica Lowova","doi":"10.5507/bp.2023.009","DOIUrl":"10.5507/bp.2023.009","url":null,"abstract":"<p><strong>Introduction: </strong>The aim of this study was to retrospectively analyse the ultrasound findings in the axillary lymph nodes in breast cancer patients with morphological changes that required biopsy. In most cases the morphological changes were minimal.</p><p><strong>Materials and methods: </strong>Between January 2014 and September 2019 examination of axillary lymph nodes with subsequent core-biopsy was performed in 185 breast cancer patients at the Department of Radiology. Lymph node metastases were detected in 145 cases, while in the remaining 40 cases benign changes or normal lymph node (LN) histology was observed. Ultrasound morphological characteristics and the sensitivity and specificity were evaluated retrospectively. Seven ultrasound characteristics were evaluated - diffuse cortical thickening, focal cortical thickening, absence of the hilum, cortical non-homogeneities, L/T ratio (longitudinal to transverse axis), type of vascularization and perinodal oedema.</p><p><strong>Results and conclusion: </strong>It is a diagnostic challenge to recognize metastases in the lymph nodes with minimal morphological changes. The most specific signs are non-homogeneities in the cortex of the lymph node as well as the absence of fat hilum and perinodal oedema. Metastases are significantly more frequent in LNs with a lower L/T ratio, in LNs with perinodal oedema and with a peripheral type of vascularization. Biopsy of these lymph nodes is necessary to confirm or exclude metastases, especially if it affects the type of treatment.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"216-222"},"PeriodicalIF":0.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9084714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges with hippocampal MR spectroscopy as a surrogate for pre-radiotherapy assessment of neurocognitive impairment in patients with brain metastasis. 将海马磁共振波谱作为放射治疗前评估脑转移患者神经认知功能障碍的替代方法所面临的挑战。
IF 0.7 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 Epub Date: 2024-04-15 DOI: 10.5507/bp.2024.012
Iveta Selingerova, Klara Holikova, Tomas Chodur, Ludmila Hynkova, Petr Pospisil, Martin Bulik, Renata Belanova, Kamila Siffelova, Ivana Kolouskova, Marek Slavik, Petr Burkon, Roman Hrstka, Radim Jancalek, Jiri Sana, Pavel Slampa, Tomas Kazda

Aim: Patients with multiple brain metastases (BM) benefit from hippocampal-avoiding whole brain radiotherapy (HA-WBRT), the challenging and less available form of WBRT. This study explores potential of pre-radiotherapy (pre-RT) hippocampal magnetic resonance spectroscopy (MRS) measuring hippocampal neuronal density as an imaging surrogate and predictive tool for assessing neurocognitive functions (NCF).

Methods: 43 BM patients underwent pre-RT hippocampal MRS. N-acetyl aspartate (NAA) concentration, a marker for neuronal density (weighted by creatine (Cr) and choline (Cho) concentrations), and neurocognitive function (NCF) tests (HVLT and BVMT) performed by certified psychologists were evaluated. Clinical variables and NAA concentrations were correlated with pre-RT NCFs.

Results: HVLT and BVMT subtests showed pre-RT deterioration except for BVMT recognition. Significantly better NCFs were observed in women in HVLT subsets. Significantly higher NAA/Cr + Cho was measured in women (median 0.63 vs. 0.55; P=0.048) in the left hippocampus (no difference in the right hippocampus). In men, a positive correlation (0.51, P=0.018) between total brain volume and HVLT-TR, between left hippocampal NAA/Cr + Cho and HVLT-R (0.45, P=0.063), and between right hippocampal NAA/Cr + Cho and BVMT-recognition (0.49, P=0.054) was observed. In women, a borderline significant negative correlation was observed between left hippocampal NAA/Cr + Cho and BVMT-TR (-0.43, P=0.076) and between right NAA/Cr + Cho and HVLT-DR (-0.42, P=0.051).

Conclusion: Borderline statistically significant correlations were observed with speculative interpretation underlying the challenges of hippocampal MRS as a surrogate for neurocognitive impairment. Further studies need to be done to ascertain the opportunities for imaging predictors of benefit from memory sparing radiotherapy.

目的:多发性脑转移瘤(BM)患者可从海马回避全脑放疗(HA-WBRT)中获益,这是一种具有挑战性且可用性较低的全脑放疗形式。本研究探讨了放疗前海马磁共振波谱(MRS)测量海马神经元密度作为评估神经认知功能(NCF)的成像替代和预测工具的潜力。对神经元密度标记物 N-乙酰天冬氨酸(NAA)浓度(通过肌酸(Cr)和胆碱(Cho)浓度加权)以及由认证心理学家进行的神经认知功能(NCF)测试(HVLT 和 BVMT)进行了评估。临床变量和NAA浓度与RT前的NCFs相关:结果:除 BVMT 识别能力外,HVLT 和 BVMT 分项测试显示出治疗前的恶化。在 HVLT 子测试中观察到女性的 NCFs 显著提高。女性左侧海马的 NAA/Cr + Cho 明显更高(中位数为 0.63 vs. 0.55;P=0.048)(右侧海马无差异)。在男性中,总脑容量与 HVLT-TR 之间呈正相关(0.51,P=0.018),左侧海马 NAA/Cr + Cho 与 HVLT-R 之间呈正相关(0.45,P=0.063),右侧海马 NAA/Cr + Cho 与 BVMT-recognition 之间呈正相关(0.49,P=0.054)。在女性中,左侧海马 NAA/Cr + Cho 与 BVMT-TR 之间(-0.43,P=0.076)以及右侧 NAA/Cr + Cho 与 HVLT-DR 之间(-0.42,P=0.051)存在近似显著的负相关:结论:海马 MRS 作为神经认知功能障碍的替代指标,其相关性在统计学上具有边际显著性,其背后隐藏着推测性解释。还需要开展进一步研究,以确定影像学预测记忆保留放疗获益的机会。
{"title":"Challenges with hippocampal MR spectroscopy as a surrogate for pre-radiotherapy assessment of neurocognitive impairment in patients with brain metastasis.","authors":"Iveta Selingerova, Klara Holikova, Tomas Chodur, Ludmila Hynkova, Petr Pospisil, Martin Bulik, Renata Belanova, Kamila Siffelova, Ivana Kolouskova, Marek Slavik, Petr Burkon, Roman Hrstka, Radim Jancalek, Jiri Sana, Pavel Slampa, Tomas Kazda","doi":"10.5507/bp.2024.012","DOIUrl":"10.5507/bp.2024.012","url":null,"abstract":"<p><strong>Aim: </strong>Patients with multiple brain metastases (BM) benefit from hippocampal-avoiding whole brain radiotherapy (HA-WBRT), the challenging and less available form of WBRT. This study explores potential of pre-radiotherapy (pre-RT) hippocampal magnetic resonance spectroscopy (MRS) measuring hippocampal neuronal density as an imaging surrogate and predictive tool for assessing neurocognitive functions (NCF).</p><p><strong>Methods: </strong>43 BM patients underwent pre-RT hippocampal MRS. N-acetyl aspartate (NAA) concentration, a marker for neuronal density (weighted by creatine (Cr) and choline (Cho) concentrations), and neurocognitive function (NCF) tests (HVLT and BVMT) performed by certified psychologists were evaluated. Clinical variables and NAA concentrations were correlated with pre-RT NCFs.</p><p><strong>Results: </strong>HVLT and BVMT subtests showed pre-RT deterioration except for BVMT recognition. Significantly better NCFs were observed in women in HVLT subsets. Significantly higher NAA/Cr + Cho was measured in women (median 0.63 vs. 0.55; P=0.048) in the left hippocampus (no difference in the right hippocampus). In men, a positive correlation (0.51, P=0.018) between total brain volume and HVLT-TR, between left hippocampal NAA/Cr + Cho and HVLT-R (0.45, P=0.063), and between right hippocampal NAA/Cr + Cho and BVMT-recognition (0.49, P=0.054) was observed. In women, a borderline significant negative correlation was observed between left hippocampal NAA/Cr + Cho and BVMT-TR (-0.43, P=0.076) and between right NAA/Cr + Cho and HVLT-DR (-0.42, P=0.051).</p><p><strong>Conclusion: </strong>Borderline statistically significant correlations were observed with speculative interpretation underlying the challenges of hippocampal MRS as a surrogate for neurocognitive impairment. Further studies need to be done to ascertain the opportunities for imaging predictors of benefit from memory sparing radiotherapy.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"206-215"},"PeriodicalIF":0.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140853684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A severe case of pemphigoid gestationis persisting after labour - case report and review of the literature. 一例严重的妊娠丘疹性荨麻疹病例在分娩后仍持续存在--病例报告和文献综述。
IF 0.7 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 Epub Date: 2023-03-14 DOI: 10.5507/bp.2023.010
Hynek Herman, Petr Krepelka, Adela T Faridova, Klara Trojanova, Jiri Hanacek, Barbora Jaluvkova, Jaroslav Feyereisl, Spyridon Gkalpakiotis

Background and aim: Pemphigoid gestationis (PG) is a rare skin disease of pregnancy. Given its incidence in pregnant women, physicians and especially obstetricians may not encounter this diagnosis in their entire career. We find this to be a major problem and there is an obligation to report it in as much detail as possible along with recommended treatments with proven efficacy.

Case report: We describe the case of a 27 year old patient who was referred to the dermatology department with severe dissemination of blisters in the 9th week of pregnancy. She was diagnosed with pemphigoid gestationis in her first pregnancy. High doses of corticosteroids were initiated but due to inadequate effect cyclosporine was added. The pregnancy was complicated with gestational diabetes. The patient gave birth in her 33rd week by caesarian section due to premature rupture of the membrane. Vesicles were seen on the newborn immediately after birth which diminished spontaneously over 2 weeks. Blisters were still seen on the patient 1 month after labor even with the combination of systemic corticosteroids with cyclosporine.

Conclusion: PG is a rare dermatosis of pregnancy. The course of the disease can be severe, necessitating systemic therapy. As described in this patient, systemic corticosteroids may not be sufficient and adding another immunosuppressive treatment may be needed. If pemphigoid gestationis has occurred during a previous pregnancy it is advised to reconsider another pregnancy.

背景和目的:妊娠斑丘疹(PG)是一种罕见的妊娠期皮肤病。鉴于其在孕妇中的发病率,医生尤其是产科医生在其整个职业生涯中可能都不会遇到这种诊断。我们认为这是一个大问题,因此有义务尽可能详细地报告这一情况,并推荐经证实有效的治疗方法:我们描述了一名 27 岁患者的病例,她在怀孕第 9 周时因严重的水疱扩散而被转诊到皮肤科。她在第一次怀孕时被诊断为妊娠丘疹性荨麻疹。医生开始使用大剂量皮质类固醇激素,但由于效果不佳,又加用了环孢素。妊娠并发症是妊娠糖尿病。由于胎膜早破,患者在第 33 周剖腹产。新生儿出生后即出现水泡,并在两周内自行消退。分娩后 1 个月,即使联合使用全身皮质类固醇激素和环孢素,患者身上仍可见水疱:结论:PG 是一种罕见的妊娠期皮肤病。结论:PG 是一种罕见的妊娠期皮肤病,病程可能很严重,需要系统治疗。正如该患者所述,全身使用皮质类固醇激素可能并不足够,可能需要增加另一种免疫抑制疗法。如果妊娠丘疹性荨麻疹发生在前一次妊娠期间,建议重新考虑再次妊娠。
{"title":"A severe case of pemphigoid gestationis persisting after labour - case report and review of the literature.","authors":"Hynek Herman, Petr Krepelka, Adela T Faridova, Klara Trojanova, Jiri Hanacek, Barbora Jaluvkova, Jaroslav Feyereisl, Spyridon Gkalpakiotis","doi":"10.5507/bp.2023.010","DOIUrl":"10.5507/bp.2023.010","url":null,"abstract":"<p><strong>Background and aim: </strong>Pemphigoid gestationis (PG) is a rare skin disease of pregnancy. Given its incidence in pregnant women, physicians and especially obstetricians may not encounter this diagnosis in their entire career. We find this to be a major problem and there is an obligation to report it in as much detail as possible along with recommended treatments with proven efficacy.</p><p><strong>Case report: </strong>We describe the case of a 27 year old patient who was referred to the dermatology department with severe dissemination of blisters in the 9th week of pregnancy. She was diagnosed with pemphigoid gestationis in her first pregnancy. High doses of corticosteroids were initiated but due to inadequate effect cyclosporine was added. The pregnancy was complicated with gestational diabetes. The patient gave birth in her 33rd week by caesarian section due to premature rupture of the membrane. Vesicles were seen on the newborn immediately after birth which diminished spontaneously over 2 weeks. Blisters were still seen on the patient 1 month after labor even with the combination of systemic corticosteroids with cyclosporine.</p><p><strong>Conclusion: </strong>PG is a rare dermatosis of pregnancy. The course of the disease can be severe, necessitating systemic therapy. As described in this patient, systemic corticosteroids may not be sufficient and adding another immunosuppressive treatment may be needed. If pemphigoid gestationis has occurred during a previous pregnancy it is advised to reconsider another pregnancy.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"271-275"},"PeriodicalIF":0.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9113246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic non-bacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO) with a focus on pamidronate therapy. 以帕米膦酸盐疗法为重点的慢性非细菌性骨髓炎(CNO)和慢性复发性多灶性骨髓炎(CRMO)。
IF 0.7 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 Epub Date: 2024-04-27 DOI: 10.5507/bp.2024.007
Katerina Bouchalova, Zuzana Pytelova

Chronic recurrent multifocal osteomyelitis (CRMO), also called chronic nonbacterial osteomyelitis (CNO) or nonbacterial osteomyelitis (NBO), is a rare autoinflammatory bone disease of unknown etiology. However, the number of patients properly diagnosed would increase with better knowledge of the disease. In this regard, whole-body magnetic resonance imaging (WB MRI) has been found to be a better predictor of active lesions than clinical examination. Importantly, the RINBO index (radiologic index for NBO) quantifies the involvement based on the WB MRI. Further, a chronic nonbacterial osteomyelitis MRI scoring (CROMRIS) has been developed as an online tool for assessing WB MRI. The therapy consists of non-steroidal anti-inflammatory drugs (NSAIDs), bisphosphonates (pamidronate, zoledronate, etc.) and other drugs, including biologics. Pamidronate is an appropriate and safe therapy. The first pilot prospective randomised controlled trial (RCT) on pamidronate vs. placebo was carried out in adults. No RCT has been done in children yet. Besides RCTs, there are a number of issues to be explored in future, i.e. predictors of therapy effect, optimal therapy duration, predictors of therapy discontinuation and evaluation of optimal therapy protocol. Recently, the CNO clinical disease activity score (CDAS) was constructed and validated but the classification criteria are still being developed. As collaboration on this rare disease is essential, a prospective Chronic Nonbacterial Osteomyelitis International Registry (CHOIR) was established to generate future comparative effectiveness research data.

慢性复发性多灶性骨髓炎(CRMO)又称慢性非细菌性骨髓炎(CNO)或非细菌性骨髓炎(NBO),是一种病因不明的罕见自身炎症性骨病。然而,随着对该疾病的进一步了解,得到正确诊断的患者人数将会增加。在这方面,全身磁共振成像(WB MRI)比临床检查更能预测活动性病变。重要的是,RINBO 指数(非细菌性鼻炎的放射学指数)可根据 WB MRI 对受累情况进行量化。此外,慢性非细菌性骨髓炎核磁共振成像评分(CROMRIS)已被开发为评估 WB 核磁共振成像的在线工具。治疗包括非甾体抗炎药(NSAIDs)、双膦酸盐(帕米膦酸盐、唑来膦酸盐等)和其他药物,包括生物制剂。帕米膦酸钠是一种合适而安全的疗法。第一项帕米膦酸钠与安慰剂的前瞻性随机对照试验(RCT)是在成人中进行的。目前还没有针对儿童的研究。除了随机对照试验外,今后还有许多问题需要探讨,如治疗效果的预测因素、最佳治疗时间、治疗中断的预测因素以及最佳治疗方案的评估。最近,CNO 临床疾病活动性评分(CDAS)已经建立并通过验证,但分类标准仍在制定中。由于这种罕见疾病的合作至关重要,因此建立了一个前瞻性的慢性非细菌性骨髓炎国际登记处(CHOIR),以生成未来的比较效果研究数据。
{"title":"Chronic non-bacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO) with a focus on pamidronate therapy.","authors":"Katerina Bouchalova, Zuzana Pytelova","doi":"10.5507/bp.2024.007","DOIUrl":"10.5507/bp.2024.007","url":null,"abstract":"<p><p>Chronic recurrent multifocal osteomyelitis (CRMO), also called chronic nonbacterial osteomyelitis (CNO) or nonbacterial osteomyelitis (NBO), is a rare autoinflammatory bone disease of unknown etiology. However, the number of patients properly diagnosed would increase with better knowledge of the disease. In this regard, whole-body magnetic resonance imaging (WB MRI) has been found to be a better predictor of active lesions than clinical examination. Importantly, the RINBO index (radiologic index for NBO) quantifies the involvement based on the WB MRI. Further, a chronic nonbacterial osteomyelitis MRI scoring (CROMRIS) has been developed as an online tool for assessing WB MRI. The therapy consists of non-steroidal anti-inflammatory drugs (NSAIDs), bisphosphonates (pamidronate, zoledronate, etc.) and other drugs, including biologics. Pamidronate is an appropriate and safe therapy. The first pilot prospective randomised controlled trial (RCT) on pamidronate vs. placebo was carried out in adults. No RCT has been done in children yet. Besides RCTs, there are a number of issues to be explored in future, i.e. predictors of therapy effect, optimal therapy duration, predictors of therapy discontinuation and evaluation of optimal therapy protocol. Recently, the CNO clinical disease activity score (CDAS) was constructed and validated but the classification criteria are still being developed. As collaboration on this rare disease is essential, a prospective Chronic Nonbacterial Osteomyelitis International Registry (CHOIR) was established to generate future comparative effectiveness research data.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"191-199"},"PeriodicalIF":0.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140853607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of graft anastomosis and graft morphology on long-term patency of the saphenous vein after aortocoronary bypass. 主动脉冠状动脉搭桥术后,移植物吻合和移植物形态对大隐静脉长期通畅的影响。
IF 0.7 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 Epub Date: 2024-04-24 DOI: 10.5507/bp.2024.013
Okaikor Okantey, Tomas Jonszta, Jiri Sieja, Miriam Kende, Radim Brat, Lubomir Pavliska

Objective: Several factors are involved in the preservation of graft function after surgical myocardial revascularization. This follow-up study aimed to evaluate the effects of vein graft anastomosis and graft morphology on long-term graft patency a minimum of 10 years after aortocoronary bypass grafting.Setting and Cohorts. This was a sub-analysis of a study that enrolled patients after isolated bypass surgery at the University Hospital Ostrava in order to evaluate the long-term graft patency of the saphenous vein after endoscopic harvest, a minimum of 10 years after aortocoronary bypass grafting.

Methods: Fifty angiograms, with a total of 90 grafts, after isolated myocardial revascularization were visualized using coronary computed tomography angiography, with 50% luminal stenosis or greater considered significant.

Results: The overall graft patency rate was 72.3%. The differences in occlusion rates between sequential and individual grafts were not statistically significant (P=0.156). All y-grafts were totally occluded. Graft and target artery diameters had a statistically significant influence on patency (P=1.000 and 0.381, respectively). Longer graft length and higher calcium scores were associated with statistically significant graft occlusion (P=0.033 and 0.005, respectively).

Conclusion: Sequential grafts can be constructed safely, especially when the goal is complete myocardial revascularization.

目的:心肌血管重建手术后,移植物功能的保持与多种因素有关。这项随访研究旨在评估静脉移植物吻合和移植物形态对主动脉冠状动脉旁路移植术后至少 10 年的长期移植物通畅性的影响。研究背景和队列。这是一项研究的子分析,该研究招募了在俄斯特拉发大学医院(University Hospital Ostrava)接受孤立搭桥手术的患者,目的是评估大隐静脉在内窥镜下采集后的长期移植物通畅性(至少在主动脉旁路移植术后 10 年):方法:使用冠状动脉计算机断层扫描血管造影术对孤立性心肌血运重建术后的 50 张血管造影进行观察,共 90 条移植物,管腔狭窄率达到或超过 50%,即为显著狭窄:结果:移植物的总体通畅率为 72.3%。结果:移植物总通畅率为 72.3%,连续移植物和单个移植物的闭塞率差异无统计学意义(P=0.156)。所有 Y 型移植物均完全闭塞。移植物和目标动脉直径对通畅率的影响有统计学意义(P=1.000 和 0.381)。较长的移植物长度和较高的钙化评分与移植物闭塞有统计学意义(分别为 P=0.033 和 0.005):结论:顺序移植物可以安全地构建,尤其是当目标是完全的心肌血运重建时。
{"title":"Influence of graft anastomosis and graft morphology on long-term patency of the saphenous vein after aortocoronary bypass.","authors":"Okaikor Okantey, Tomas Jonszta, Jiri Sieja, Miriam Kende, Radim Brat, Lubomir Pavliska","doi":"10.5507/bp.2024.013","DOIUrl":"10.5507/bp.2024.013","url":null,"abstract":"<p><strong>Objective: </strong>Several factors are involved in the preservation of graft function after surgical myocardial revascularization. This follow-up study aimed to evaluate the effects of vein graft anastomosis and graft morphology on long-term graft patency a minimum of 10 years after aortocoronary bypass grafting.Setting and Cohorts. This was a sub-analysis of a study that enrolled patients after isolated bypass surgery at the University Hospital Ostrava in order to evaluate the long-term graft patency of the saphenous vein after endoscopic harvest, a minimum of 10 years after aortocoronary bypass grafting.</p><p><strong>Methods: </strong>Fifty angiograms, with a total of 90 grafts, after isolated myocardial revascularization were visualized using coronary computed tomography angiography, with 50% luminal stenosis or greater considered significant.</p><p><strong>Results: </strong>The overall graft patency rate was 72.3%. The differences in occlusion rates between sequential and individual grafts were not statistically significant (P=0.156). All y-grafts were totally occluded. Graft and target artery diameters had a statistically significant influence on patency (P=1.000 and 0.381, respectively). Longer graft length and higher calcium scores were associated with statistically significant graft occlusion (P=0.033 and 0.005, respectively).</p><p><strong>Conclusion: </strong>Sequential grafts can be constructed safely, especially when the goal is complete myocardial revascularization.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"223-228"},"PeriodicalIF":0.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140872212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biomedical Papers-Olomouc
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1